Studies on the biosynthesis of glycosaminoglycans (GAGs) in mammalian and bacterial systems have revealed similarities with regard to polymerization mechanisms and the enzymes involved. Several of the basic features of the biosynthetic machinery in diverse organisms seem to be conserved, such that bacteria may provide potential model systems for the investigation of polysaccharide biosynthesis in eukaryotic systems. Figure 1A) .
Studies on the biosynthesis of glycosaminoglycans (GAGs) in mammalian and bacterial systems have revealed similarities with regard to polymerization mechanisms and the enzymes involved. Several of the basic features of the biosynthetic machinery in diverse organisms seem to be conserved, such that bacteria may provide potential model systems for the investigation of polysaccharide biosynthesis in eukaryotic systems. hexosamine and uronic acid units. They are classified according to their hexosamine units, where heparinlHS and HA are glucosaminoglycans and CS/DS are galactosaminoglycans. Heparin/HS and CS/DS are sulphated polymers, which together with the uronic acids, give rise to highly negatively charged chains ( Figure 1A) .
Structure of GAGs
Heparin has the highest negative-charge density of any known biological macromolecule. The different sulphation patterns contribute to the enormous heterogeneity found within and between the polymers. Heparin/HS can be N-sulphated on glucosamine and 0-sulphated at various positions on the monosaccharide units, and the hexuronic acid can be either glucuronic or iduronic acid. All 'sequences' that can be found in heparin also occur in HS, which differs from heparin in HA differs from the other mammalian GAGs in the sense that it is a non-sulphated homogeneous polymer (Figure 1) 
Biosynthesis of mammalian GAGs
The biosynthesis of PG chains occurs mainly in the Golgi apparatus. A tetrasaccharide, GlcAGal-Gal-Xyl, attached to a serine in the core protein provides the starting point for the polysaccharide chain polymerization. Heparin/ HS and CS/DS utilize the same tetrasaccharide linkage as a primer for the GAG chains, and addition of the first GlcNAc or GalNAc unit to the linker determines whether a glucosaminoglycan or a galactosaminoglycan will be synthesized. The enzymes catalysing the transfer of the first hexosamines differ from the enzymes catalysing the polymerization, but how the biosynthesis is directed into one path or another is not clearly 
HA is synthesized at the cell membrane [14] . The mechanism of chain elongation has not been conclusively established, although it has been suggested to involve addition of the monosaccharide units one by one to the reducing end of the polymer [15] .
Biosynthesis of bacterial GAGs
In E. colz, polymerization of the K5 and K4 polysaccharide occurs inside the cell on the cytoplasmic membrane, and the polysaccharides are then translocated through the bacterial membranes and transported out of the organism [16] . The attachment site of the reducing termini of the bacterial polysaccharides during polymerization has not been conclusively identified. K5 polysaccharides isolated from the bacterial capsule have been shown to contain 2-keto-3-deoxyoctonate (KDO) and phosphatidic acid at the reducing end; however, polysaccharide isolated from K5 bacteria deficient in translocation mechanisms and thus with the polysaccharide appearing inside the cell lacked KDO at the reducing end [17] . It therefore seems likely that KDO is added to the polymer during the translocation of the polysaccharide out of the cell.
Polymerization reactions
The glycosyltransferases involved in GAG polymerization possess special features that enable the production of a polymer composed of two alternating types of sugar units. The two enzymes act in concert, in a repetitive manner, adding 80 monosaccharide units or more/min in a cell-free system [18] . Indeed, recent findings suggest that GAGs are polymerized by a special type of enzyme that expresses two different glycosyltransferase activities in a single protein. The first observation to raise this hypothesis was that a single mutation has eliminated both GlcNAcand GlcA-transferase activities in a Chinese hamster ovary cell line defective in HS biosynthesis [ 191. Further, during purification of these glycosyltransferases from a soluble form found in bovine serum, the two activities were found to associate with the same approx. 70 kDa protein [20] . It is interesting to note that the first polymer-modification reactions in HS biosynthesis, N-decatylation and N-sulphation of GlcNAc units, are catalysed by one protein with two catalytic sites. More than one catalytic activity in one protein seems to be a way to organize the biosynthetic machineries of GAGs.
In order to study the actual polymerization process, intact membrane complexes seem to be necessary. In microsomes containing Golgi membranes from mouse mastocytoma, polymerization of heparin or CS can easily be achieved by addition of the appropriate UDP-sugars [ 181. However, once the membranes are solubilized, the polymerization stops, although each separate glycosyltransferase activity may still be assayed by measuring transfer of a single monosaccharide unit to the appropriate oligosaccharide acceptors [ 13,211. All reports dealing with HA synthase activity detect polymerization activity as incorporation of radiolabelled sugars into a polysaccharide. So far, no attempt to assay transfer of monosaccharide units to an exogenous HA oligosaccharide acceptor has been described. The only information available on the actual polymerization mechanism derives from the early pulse-chase studies by Prehm [15] , who suggested that the HA chain is elongated at the reducing end. In addition to problems in assaying these membrane-bound enzymes, there are also difficulties in preserving the activities of the glycosyltransferases in solubilized form. Glycosyltransferases involved in both HS and CS biosynthesis have been solubilized in active form but they are difficult to purify. A major advance was the finding of a soluble truncated form of HS polymerase in serum [ZO] . CS polymerases have recently also been found in bovine serum, which will, it is hoped, facilitate the purification of these enzymes [ 1 11.
In the E. coli K5 bacterium, the polymerase activity was assessed by the amount of polysaccharide formed after the addition of UDPsugars to membrane fractions [22] . All such activity was abolished after solubilization of K5 membranes in 1% Triton X-100. Howver, using the appropriate oligosaccharides derived from the K5 capsular polysaccharide as acceptors, we could demonstrate separate addition of both GlcA and GlcNAc monosaccharide units to the non-reducing ends of the oligosaccharides.
Interestingly, the E. coli K5 enzymes could also transfer monosaccharide units to N-sulphated acceptor substrates, similar to the mammalian enzymes [23] , even though the bacterium does not synthesize a sulphated polymer. In our experiments, the polymerization enzymes from heparin-producing mastocytoma and from the K5 bacterium show similar behaviour in terms of polymerization mechanism, kinetics, substratespecificity, etc. The study of the polymerization reaction of the E. coli K4 polysaccharide is a more delicate problem, since the CS backbone is substituted with a fructose unit ( Figure 1B) . The sugar precursor for the fructose unit is not known nor is it known at what stage of the biosynthesis it is added to the polymer. T o address this problem, different acceptor oligosaccharides derived from the K4 polysaccharide were prepared. Chondroitin oligosaccharides with a non-reducing terminal GalNAc unit were incubated with UDP-['4C]GlcA and solubilized K4 enzymes, and oligosaccharides with a terminal GlcA unit were similarly incubated with UDP-[3H] GalNAc. Digestion of the radiolabelled oligosaccharide products with P-glucuronidase and P-N-acetylhexosaminidase respectively resulted in the release of labelled monosaccharides, thus proving that they had been incorporated at the nonreducing end of the oligosaccharides. It is concluded that the bacterial enzymes add sugar units to the nascent polymer in the same way that mammalian enzymes act in the biosynthesis of CS [24] . K4 oligosaccharides ending with a GalNAc unit and with fructose units retained in the polymer did not serve as acceptors for the GlcA-transferase. This finding suggests that the fructose units are added to the polymer after formation of the chondroitin backbone. The genome of the biosynthetic complex for E. coli K5 capsular polysaccharide has been characterized in several studies [25, 26] . Again, the GlcNAc-and GlcA-transferase seem to reside in a single (60 kDa) protein.
The same concept, one protein with two catalytic sites, is also proposed for HA synthase in Streptococcus [27] . Another interesting finding from studies of both E. coli K5 and Streptococci genomes is that the polymerase-encoding genes are located directly upstream of the gene coding for UDP-glucose dehydrogenase (UDPGDH) [26, 28] .
Role of UDPGDH
UDPGDH is the enzyme that converts UDP-Glc into UDP-GlcA, i.e. one of the two sugar precursors in GAG synthesis. In bacteria, UDPGDH is probably acting in close association with the polymerase, whereas mammalian GAG synthesis occurs in the Golgi and UDP-GlcA is synthesized in the cytosol. Transporters into the Golgi for both UDP-GlcA and UDP-Glc have been demonstrated, but it has not been investigated whether UDPGDH can also form UDP-GlcA inside the Golgi vesicles in association with the polymerases. UDPGDH also has a key role in the formation of UDP-Xyl, since it is formed by decarboxylation of UDP-GlcA. UDP-Xyl is the precursor for the first sugar unit that links the GAG chains to the protein core.
UDPGDH from bovine liver has been sequenced at the amino acid level but no mammalian cDNA has been described [29] . We have screened a bovine kidney cDNA library and cloned the bovine UDPGDH (Lidholt, K., Hjertson, E. and Lind, T., unpublished work). Using sequences derived from bovine UDPGDH as probes, we also cloned a protein from the plant Arabidopsis thaliana which shows 60% identity with the bovine clone at the amino acid level (Figure 3 ). In the plant, UDPGDH has been implicated as a key regulatory enzyme for the metabolism of UDP-sugars, with the role of modulating the composition of the cell-matrix polysaccharides [30-341. A high degree of sequence homology is shown also with bacterial UDPGDHs, as indicated by the asterisks in Figure 3 .
UDPGDH is obviously a highly conserved protein in separate branches of the evolutionary system. Polysaccharide-synthesizing enzyme complexes seem to have appeared early in evolution and have retained their main features in bacteria, mammals and to some degree also in plants. 
